trifluoperazine has been researched along with Arthritis, Rheumatoid in 1 studies
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janczi, T | 1 |
| Böhm, BB | 1 |
| Fehrl, Y | 1 |
| DeGiacomo, P | 1 |
| Kinne, RW | 1 |
| Burkhardt, H | 1 |
1 other study available for trifluoperazine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
ADAM15 in Apoptosis Resistance of Synovial Fibroblasts: Converting Fas/CD95 Death Signals Into the Activation of Prosurvival Pathways by Calmodulin Recruitment.
Topics: ADAM Proteins; Anilides; Apoptosis; Arthritis, Rheumatoid; Calmodulin; Cell Line; Chondrocytes; Fas | 2019 |